Abstract: A hair care product contains a yolk antibody (a yolk-derived, anti-hair antibody) which has been obtained from an egg of a domestic fowl immunized using, as an antigen, whole human hair, e.g., normal human hair or human hair damaged by permanent waving, dyeing or bleaching, hair particles obtained by grinding constituent tissues of human hair, the keratin protein extracted from the human hair, or a hydrolysate of the keratin protein.

Abstract: A method of using a topically applied skin sensitizer dispersed in a manually applied vehicle which substantially increases tissue sensation. The principal ingredient is benzalkonium chloride in a water soluble gel which includes sorbitol, glycerin, hydroxethylcellulose and propylene glycol.

Abstract: Relatively high VOC hair styling compositions which provide good style retention without unacceptable stickiness or stiffness are disclosed. The compositions comprise from about 0.01% to about 20% of a hair styling polymer and a carrier comprising at least about 0.5%, by weight of the composition, of a first solvent selected from the group consisting of water; water soluble organic solvents; organic solvents which are strongly to moderately strong in hydrogen-bonding parameter; and mixtures thereof; wherein the first solvent is other than a C.sub.1 -C.sub.3 monohydric alcohol, a C.sub.1 --C.sub.3 ketone and a C.sub.1 -C.sub.3 ether, wherein the composition is characterized by a FFV and a CRI wherein (FFV.sup.-1 .times.1000).gtoreq.[(-2.635.times.CRI)+36.418].

Abstract: An aqueous foaming cosmetic composition comprising (a) from 0.1 to 7% of an imidazolinium amphoteric surfactant, (b) from about 0.1% to about 5.0% of a polyol alkoxy ester wherein the ratio of (a):(b) is from about 15:1 to about 1:1 and wherein the cleansing composition has a viscosity of at least about 150 cps (Brookfield RVT, Spindle No TB, 10 rpm, 25.degree. C.). The composition has improved foam stability, together with excellent cleansing performance and mildness. It is suitable for use as make-up and facial cleansers, foam bath, shower products, shampoos etc.

Abstract: Disclosed are methods for treating vesicoureteral reflux in a mammal wherein a composition comprising a water insoluble biocompatible polymer and a biocompatible solvent is delivered to the subureteral tissue of the mammal.

Abstract: This invention relates to an improved herbal-based decongestant and antihistamine nasal spray which includes known constituents in specific ratios and further includes a saponin. The invention further relates to a method for treating nasal congestion which results in enhanced decongestant action and surprising curative effects.

Abstract: There is disclosed a method for treating high grade astrocytoma, especially brain stem glioma, in a child by administering to a child in need of such treating an amount of temozolomide sufficient to achieve a clinical response. Preferred dosing schedules are provided.

Abstract: A process for making a fast melt tablet and a powdered material is disclosed. The process includes providing a powdered material with a density of from 0.2 to about 0.55 grams and precompacting the material to increase the density prior to compacting the powdered material into a fast melt tablet.

Abstract: A method of preventing or alleviating a migraine headache in a patient subject to migraine headaches comprises administering to the patient daily, for an effective period of time, a daily effective amount of a dietary supplementation of serotonin and norepinephrine precursors to increase the level of serotonin and norepinephrine in the patient.

Abstract: There is disclosed a method for treating cancer in a patient in need of such treating comprising administering temozolomide in an amount sufficient to achieve a clinical response wherein the temozolomide is administered more than once per day. Preferred specific dosing schedules are provided.

Abstract: A composition and method of treatment of anhidrosis in horses and other animals wherein the horses or other animals are given three dosages of sublimed sulfur and powdered milk sugar daily.

Abstract: An analgesic cosmetic formulation in the form of an ointment, salve or cream which is applied to the skin, including the hands and feet for the treatment of such conditions as redness, swelling, itching and soreness of the skin. The cosmetic formulation contains ingredients including oranges, avocado, watermelon, banana, lemon, palm oil, coconut oil, petroleum jelly, beeswax, aloe vera, vitamin E, aspirin, ammonium sulfate, sodium bisulfate and quine sulfate.

Abstract: A controlled release preparation comprises an ionic polymer matrix loaded with an active compound, particularly a pharmaceutically active compound such as doxorubicin or other cytotoxic or cytostatic drug, the active compound being complexed with a complexing agent such as a metal ion to modify the release of the active compound from the polymer matrix. The ionic polymer matrix may be provided in the form of microspheres, such as microspheres of crosslinked albumin/dextran sulphate.

Abstract: For the purpose of applying, over the surface of the skin, active substances which irritate the skin or smell bad. A glove is manufactured from foil with a coating that contains microcapsules that can be burst open by pressure, and the active substance applied to the skin.

Abstract: The invention relates to a process of making pharmaceutical dosage units comprising at least desogestrel or Org 30659 (17.alpha.-17-hydroxy-11-methylene-19-norpregna-4,15-dien-20-yn-3-one), present in an amount of about 0.005 to 1.0 percent by weight of each pharmaceutical dosage unit, characterized in that the steroidal agent, and when required pharmaceutically acceptable excipients, are mixed with water and granulated.

Abstract: A cosmetic composition for the skin, including the scalp, comprising (a) at least one specific ester which is a monoester of a C.sub.4 -C.sub.10 aliphatic acid and a C.sub.16 -C.sub.18 aliphatic alcohol, and (b) hollow particles exhibiting a mean particle size ranging from 1 .mu.m to 300 .mu.m. This composition can be used as face cleanser, deodorant, and, in particular, as a shaving product.

Abstract: A highly effective pure, natural, ingestible antidiabetic may be made from Shilianhua (Echevaria glauca, Sinocrassula berger, Crassulaceae) by washing leaves and/or stems of the Shilianhua plant, crushing them in a grinder, breaking the cell walls to form a filterable material, filtering the material to produce a filtrate, and decompressing and concentrating the filtrate to produce a concentrated solution. The cell walls may be broken using medical alcohol, quick freezing and thawing, or ultrasonic mixing. The concentrated solution is then made into a powder, or concentrated powder, by baking, crushing, and passage through a 60 mesh screen; using a silica gel column; using a Saphadex column; or by treatment with a CH.sub.3 COOC.sub.2 H.sub.5 solution. Treatment of, or to prevent, diabetes by lowering blood sugar at least 10% (e. g.

Abstract: An extrudable allograft bone tissue material for filling surgical sites can be made from mineralized or demineralized cortical, cancellous, or cortical/cancellous bone powder. A method is disclosed for reconstituting the bone powder in a syringe which includes the steps of placing lyophilized bone material of predetermined mixed size in a syringe barrel having a distal circular opening that ranges in diameter from about 8 mm to about 15 mm and adding a volume of sterile fluid to wet the bone powders. The excess sterile fluid is drained through the bone allowing the fluid to remain in constant engagement with the bone for a period of time until the mass is fully reconstituted from its initial lyophilized state and attains self-adherence so that the mass conforms to the shape of the barrel of the syringe and retains the barrel shape and integrity after extrusion from the syringe into the surgical site in a semisolid mass.

Abstract: Pharmaceutical formulations for oral administration, comprising a matrix which comprises a .beta.-lactam antibiotic optionally in combination with a .beta.-lactamase inhibitor, granules in a delayed release form dispersed within the matrix, which comprise a .beta.-lactam antibiotic optionally in combination with a .beta.-lactamase inhibitor, the overall tablet formulation including a .beta.-lactam antibiotic and a .beta.-lactamase inhibitor.

Abstract: A superior enteric formulation of the antidepressant drug, fluoxetine, is in the form of enteric pellets of which the enteric layer comprises hydroxypropylmethylcellulose acetate succinate.